Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
3
result was found. Results that relate to
Cost-effectiveness analysis
Cost-effectiveness analysis of abemaciclib plus fulvestrant in the second-line treatment for HR﹢/HER2﹣ advanced breast cancer
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1259-1266.
1457 times
524 times
Xi ZHAO
Xi YAN
Ning LI
Chun-Xia HOU
Abemaciclib
Fulvestrant
Hormone receptor-positive breast cancer
Markov model
Cost-effectiveness analysis
Details
Cost-effectiveness analysis of enzalutamide in the treatment of metastatic prostate cancer
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(3):269-276.
1028 times
517 times
YANG Lei
WANG Fengling
HUANG Ling
LI Yan
ZHENG Hanrui
ZHENG Lingli
CHEN Li
Enzalutamide
Metastatic prostate cancer
Markov model
Cost-effectiveness analysis
Details
Research progress of equity-informative health economic evaluation
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(8):929-937.
1143 times
281 times
FANG Nan
HE Xiaoning
WU Jing
Economic evaluation
Equity
Equity-based weighting
Distributional cost-effectiveness
Extended cost-effectiveness analysis
Details
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University